(Q73200656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

congestive heart failure

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Gianluca Pontone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Piergiuseppe Agostoni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

P Palermo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Susini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1038-1043

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Endothelium as a therapeutic target in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Additive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted Normotensives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Optimizing the exercise test for pharmacological investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Cardiopulmonary exercise testing for evaluation of chronic cardiac failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Improvement in exercise capacity of candidates awaiting heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Lung function and exercise gas exchange in chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900495-6

10.1016/S0002-9149(99)00495-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10569660%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference